Fundraising Fox20/20 HealthCare Partners LLC
Venture capitalAuburndale · Seed–Late Stage · 7 people tracked
Find your way into 20/20 HealthCare Partners LLC
Each arrow is one introduction. Sign up to fill in the first one.
Ask Christine Bunt to introduce you to Hillel Bachrach
You →Christine · together at Verseau Therapeutics →Hillel
Ask Jamie Chen to introduce you to Dr. Zafrira Avnur
You →Jamie · together at Variantyx →Dr.
Ask Sam Okafor to introduce you to Haim Neerman
You →Sam · together at Variantyx →Haim
- Jonathan Fleming7 people can intro you
Sign up to find every way you can get introduced to 20/20 HealthCare Partners LLC
- Your email: who you already know at 20/20 HealthCare Partners LLC, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the 20/20 HealthCare Partners LLC team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
20/20 HCP invests at the early stage of life sciences and healthcare technology, targeting companies in diagnostic imaging, medical devices, healthcare IT, biotechnology and pharmaceuticals. It focuses on the phase after proof of concept has been established, funding program development through to the completion of verification and validation studies (pre-regulatory approval and pre-commercialization). It typically acts as lead investor providing managerial and operational support alongside capital, aiming for short investment periods of about 2-3 years to exit and returns in the 3-7x range, with exit routes including sale, licensing, partnership with big pharma, or a follow-on financing round.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 10 of 17 portfolio companiesHealthtech ×9Biotech ×5Medical Devices ×4AI & Machine Learning ×3Digital Health ×2Cloud Computing ×1Deep Tech ×1Enterprise Software ×1
HQs:United States×7
Investments · 17 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 12017 · 13 dated
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology.
AI & Machine LearningBiotechDigital HealthHealthtechFramingham, US
Haim Neerman(Co-founder)inTomer Jackman(Co-founder & VP Customer Support and Lab Services)inJeffrey Weisberg(Chief Financial Officer)inYaron Rachmany(Operations, R&D, IT (executive))inChristine Stanley(Chief Genomics and Compliance Officer)inEyal Reinstein(Chief Medical Officer)in
Co-investorsBosch VenturesNew Era Capital PartnersOrbiMedPeregrine VenturesPitangoQuark Venture Inc.+3 more
Coagulo develops a portable point-of-care testing platform for coagulation disorder diagnosis and management using microfluidic technology and data analytics.
BiotechDeep TechHealthtechMedical Devices
PartnerHillel Bachrach· solo GP
Co-investorsGood Growth CapitalNew World AngelsService Provider Capital
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in
PartnerHillel Bachrach· led
Co-investorsDolby Family VenturesFlucas VenturesTachyon VenturesVU Venture PartnersAmgen VenturesFounders Fund
Remedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer.
BiotechHealthtechRockville, US
Gregory Plan Crimmins(Executive Officer, Director)
PartnerHillel Bachrach· solo GP
Co-investorsSchooner CapitalAlexandria
UltraSPECT develops image reconstruction technology that enables lower-dose and faster nuclear cardiology, oncology, and bone imaging exams.
AI & Machine LearningHealthtechMedical Devices
PartnerHillel Bachrach· solo GP
Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients.
AI & Machine LearningBiotechHealthtechMedical DevicesAuburndale, US
Bob Langer(Director, Promoter)Dan Anderson(Executive Officer, Director, Promoter)inTatiana NovobrantsevainIgor FeldmaninWalter Capone(Executive Officer)Christine Bunt(Executive Officer, Director)in
PartnerHillel Bachrach· led
Co-investorsHighlight CapitalYonghua Capital
XR therapeutics platform company that merged with Amelia Virtual Care.
HealthtechNeedham, US
Eran Orr(Founder & Chief Executive Officer)in
PartnerHillel Bachrach· solo GP
Co-investorsAI CapitalAsabys PartnersBridges IsraelFlying Tiger CapitalKeyhorse CapitalNOVA Prime
Zixi provides software solutions for broadcast and live video workflows, serving content owners, broadcasters, service providers, sports organizations, and OTT providers with capabilities for content contribution, satellite replacement, B2B distribution, and direct-to-consumer enablement.
Cloud ComputingEnterprise SoftwareMedia & EntertainmentSaaS
Uri Avni(Co-Founder, CTO)
PartnerHillel Bachrach· led
Co-investorsSchooner Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Corindus Vascular RoboticsEnclearHighRadNEMDXPhysIQQBiotixSQZ BiotechnologyVelocompViztek
Exits · 2
2 acquisitionsViztekacq. by Konica MinoltaZixiacq. by Clearhaven Partners
Portfolio news
latest coverage across their companiesRemedy Plan · finsmes.com · May 13, 2025
Frequently asked questions
- How many investments has 20/20 HealthCare Partners LLC made?
- 20/20 HealthCare Partners LLC has 17 tracked investments, 2 of which have exited.
- What stage does 20/20 HealthCare Partners LLC invest at?
- 20/20 HealthCare Partners LLC invests at the Seed, Series A, Growth, Late Stage stages.
- What sectors does 20/20 HealthCare Partners LLC focus on?
- 20/20 HealthCare Partners LLC focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Media & Entertainment, Medical Devices.
- Where is 20/20 HealthCare Partners LLC located?
- 20/20 HealthCare Partners LLC is headquartered in Auburndale, US.
- Does 20/20 HealthCare Partners LLC lead rounds?
- Yes, 20/20 HealthCare Partners LLC leads investment rounds.
- Who does 20/20 HealthCare Partners LLC co-invest with?
- 20/20 HealthCare Partners LLC most often shares deals with Flying Tiger Capital, Schooner Capital, AI Capital, among 18 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.